Cargando…
Mevalonate kinase somatic mosaicism and bigenic genotypes may explain heterogeneity in mevalonate kinase deficiency
Autores principales: | Shinar, Y, Hashkes, PJ, Cohen, R, Kessel, A, Tirosh, I, Padeh, S, Arostegui, J, Livneh, A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599907/ http://dx.doi.org/10.1186/1546-0096-13-S1-P48 |
Ejemplares similares
-
Mevalonate kinase deficiencies: from mevalonic aciduria to hyperimmunoglobulinemia D syndrome
por: Haas, Dorothea, et al.
Publicado: (2006) -
Diagnostic value of urinary mevalonic acid excretion in mevalonate kinase deficiency (MKD)
por: Jeyaratnam, Jerold, et al.
Publicado: (2014) -
Tocilizumab for the Treatment of Mevalonate Kinase Deficiency
por: Rafiq, Nadia K., et al.
Publicado: (2018) -
Mevalonate kinase deficiency: current perspectives
por: Favier, Leslie A, et al.
Publicado: (2016) -
Mevalonate Kinase-Associated Diseases: Hunting for Phenotype–Genotype Correlation
por: Boursier, Guilaine, et al.
Publicado: (2021)